Global Pharmaceutical News

The European Commission and international health agencies are closely monitoring a growing incidence of avian influenza in mammals.

EU chemical and pharmaceutical trade: robust growth. [Quantung Pharma – Quantung.com]

Biden administration to provide free Covid vaccines to uninsured Americans this fall through end of 2024

The health area has never been as focused on data as it is today. From the control of expenses to the detection of fraud and the coordinatio

UnitedHealth stock jumps after earnings top estimates despite rising medical costs

A Degree in Health Science Could Be Just What the Doctor Ordered

The FDA has placed a clinical hold on Hemogenyx Pharmaceuticals’ investigational HEMO-CAR-T, which is being trialed for the treatment of acu

Amid declining demand for COVID-19 vaccines, embattled biotech Novavax is revising its advanced purchase contract with Canada’s department o

Friday, BrainStorm Cell Therapeutics posted positive Phase III data for its amyotrophic lateral sclerosis candidate NurOwn, showing that the

angioedema patients treated with Intellia’s NTLA-2002—an in vivo CRISPR-Cas9 therapy— had an average 95% reduction in the sudden, debilitati

The therapy becomes an option for moderate-to-severe plaque psoriasis in certain adults

Pioneer Group has announced a partnership with King’s College London to launch new dedicated start-up incubators in biotech and medtech on t

Johnson & Johnson has capitalized on the shaky financial ground at French biotech Nanobiotix by licensing its lead product, NBTXR3, intended

Chinese biotech BeiGene has acquired an exclusive license of an investigational antibody-drug conjugate for $1.3 billion from Shanghai-based

A project involving researchers based in Edinburgh wants to establish effective combinations of existing drugs which, used together, could t

GLORIA trial shows increased survival levels among newly diagnosed brain cancer patients TME Pharma – a company concentrating on the develo

Project aims to boost the adoption of technology across London’s NHS and help patients manage conditions

PrecisionLife to analyse OXEGENE data to improve mechanistic understanding of endometriosis

ELATIVE, a randomised PBC trial involving 161 patients, has successfully met its primary endpoint

Therapy has been developed to reduce the frequency, duration and severity of migraine attacks